Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Suplineuro Plus
- Development stage
- Unknown
- Lead developer
- Neurogenics Therapeutics
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Suplineuro Plus is a multi-ingredient nutraceutical formulation developed by Neurogenics Therapeutics, specifically designed to support nerve health and manage symptoms associated with peripheral neuropathy, including diabetic neuropathy. The product combines high-dose methylcobalamin (Vitamin B12), alpha-lipoic acid, pyridoxine (Vitamin B6), and folic acid. Methylcobalamin acts as a vital cofactor for methionine synthase, which is essential for the synthesis of the myelin sheath and nerve regeneration. Alpha-lipoic acid serves as a potent antioxidant that neutralizes free radicals, improves endoneurial blood flow, and reduces oxidative stress-induced nerve damage. Pyridoxine and folic acid provide critical metabolic support for neurotransmitter synthesis and cellular repair. Together, these components work synergistically to alleviate neuropathic symptoms such as numbness, tingling, and burning sensations.
- Brand names
- Suplineuro Plus
02
Targets
MTR (Methionine synthase)CBS (Cystathionine beta-synthase)DHFR (Dihydrofolate reductase)
Beyond the preview
Go deeper on Suplineuro Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Suplineuro Plus.